Veterinary Medicines

Drontal Dog Tasty Bone XL 525/504/175 mg Tablets

Authorised
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Drontal Dog Tasty Bone XL 525/504/175 mg tablets
Drontal Dog Tasty Bone XL 525/504/175 mg Tablets
Active substance:
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    525.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    175.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    504.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 06462/3019
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0335/002
Concerned member states:
  • Austria
  • Denmark
  • Finland
  • France
  • Germany
  • Iceland
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 26/08/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."